- Coordinator
- Centre Hospitalier Regional Et Universitaire De Brest, France
- Runs
- 1 December 2023 to 30 November 2028
- Status
- Running
- EU funding
- €10.0m
- Total cost
- €10.0m
- Partners
- 20 organisations in 8 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101095698
What the project is doing
In the project's own words, from its summary on CORDIS.
Venous thromboembolism (VTE) is a frequent and life-threatening disease. In 50% of cases, VTE occurs in the absence of any major risk factors (unprovoked VTE). In these patients, when anticoagulation is stopped after 3 months of anticoagulation, more than 35% will develop recurrent VTE. Consequently, international guidelines recommend to treat these patients “indefinitely”. However, such practice exposes them to a substantial increase risk of bleeding.
Nevertheless, after several years of anticoagulation in all patients with unprovoked VTE, the risk of anticoagulant-related bleeding is expected to exceed the risk of recurrent VTE after stopping treatment. In addition, extending anticoagulation indefinitely in all patients with unprovoked VTE exposes 65% of patients to an unjustified high risk of bleeding, who would never have experienced recurrent VTE after stopping treatment.
In this setting, optimal duration and management of anticoagulation remains a pivotal and unresolved challenging issue which has the potential to markedly improve long-term prognosis of unprovoked VTE. Based on quantitative and qualitative approaches, MORPHEUS will for the first time integrate (i) clinical, laboratory and imaging biomarkers (personalized medicine) and (ii) socio-anthropological markers (patient-centred model) into sets of prediction rules for optimizing anticoagulant management integrated in a shared decision-making process.
The ultimate goal of the European “MORPHEUS” project will be to develop and validate a time-dependent multi-component tool integrated in a shared decision-making process regarding anticoagulant treatment duration in patients with unprovoked VTE. The whole MORPHEUS program, leaded by a consortium of outstanding European researchers in the field of VTE, will constitute a major breakthrough compared with the present standard of care in patients with unprovoked VTE with major scientific, public health, economic, and societal impacts.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Centre Hospitalier Regional Et Universitaire De Brest | Brest | France | Coordinator |
| Universite De Geneve | Geneve | Switzerland | Associatedpartner |
| Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz | Mainz | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Region Syddanmark | Vejle | Denmark | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Fundacion Instituto De Investigacion Marques De Valdecilla | Santander | Spain | Third party |
| Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal | Madrid | Spain | Third party |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Assistance Publique Hopitaux De Paris | Paris | France | Participant |
| Ecrin European Clinical Research Infrastructure Network | Paris | France | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite De Bordeaux | Bordeaux | France | Participant |
| Universite De Brest | Brest | France | Third party |
| Universite Paris Cite | Paris | France | Participant |
| Academisch Ziekenhuis Leiden | Leiden | Netherlands | Participant |
| Todaytomorrow B.v. | Rotterdam | Netherlands | Participant |
| Uniwersytet Medyczny Im Piastow Slaskich We Wroclawiu | Wroclaw | Poland | Third party |
| Warszawski Uniwersytet Medyczny | Warszawa | Poland | Participant |
| Kungliga Tekniska Hoegskolan | Stockholm | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI